Showing results (81-90 of 150) with videos related to

Sort By:
Pageof 15
BMJ Public Health|November 10, 2025
Network analysis of demographics, dietary habits and health-related quality of life among northern Chinese populationSamuel Chacha, Hui Jing, Yuxin Teng, et al.
Frontiers in Molecular Biosciences|May 24, 2021
Efficacy and Safety of Combination Treatment With Apatinib and Osimertinib After Osimertinib Resistance in Epidermal Growth Factor Receptor-Mutant Non-small Cell Lung Carcinoma-A Retrospective Analysis of a Multicenter Clinical StudyXue Yang, Yang Xia, Liyan Xu, et al.
The Journal of Nutritional Biochemistry|March 7, 2025
Time-restricted feeding mitigates HFD-induced sarcopenic obesity in aging mice through improving the sensitivity of FGF21Ting Wang, Hongkun Lin, Yan Deng, et al.
Cancer Medicine|April 8, 2022
The prevalence and real-world therapeutic analysis of Chinese patients with KRAS-Mutant Non-Small Cell lung cancerHanxiao Chen, Dingzhi Huang, Gen Lin, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 23, 2018
Survival difference between <i>EGFR</i> Del19 and L858R mutant advanced non-small cell lung cancer patients receiving gefitinib: a propensity score matching analysisMinglei Zhuo, Qiwen Zheng, Jun Zhao, et al.
Oncotarget|April 7, 2015
miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathwayChunlei Ge, Shikai Wu, Weiwei Wang, et al.
BMC Cancer|July 19, 2020
A nomogram model to predict death rate among non-small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) databaseBo Jia, Qiwen Zheng, Jingjing Wang, et al.
Nutrients|July 13, 2024
Does Serum Uric Acid Mediate Relation between Healthy Lifestyle and Components of Metabolic Syndrome?Yan Huang, Hui Jing, Ziping Wang, et al.
Thoracic Cancer|July 31, 2018
Analysis of topoisomerase I expression and identification of predictive markers for efficacy of topotecan chemotherapy in small cell lung cancerChunxin Lv, Xiuju Liu, Qiwen Zheng, et al.
Cancer Medicine|March 20, 2016
A prognostic model for platinum-doublet as second-line chemotherapy in advanced non-small-cell lung cancer patientsHongnan Mo, Xuezhi Hao, Yutao Liu, et al.
Pageof 15